Risk-adapted treatment reduced chemotherapy exposure for clinical stage I pediatric testicular cancer
Abstract Background Different from adult clinical stage I (CS1) testicular cancer, surveillance has been recommended for CS1 pediatric testicular cancer. However, among high-risk children, more than 50% suffer a relapse and progression during surveillance, and adjuvant chemotherapy needs to be admin...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-12-01
|
| Series: | BMC Medical Informatics and Decision Making |
| Online Access: | https://doi.org/10.1186/s12911-020-01365-x |